35682458|t|Hepcidin (rs10421768), Transferrin (rs3811647, rs1049296) and Transferrin Receptor 2 (rs7385804) Gene Polymorphism Might Be Associated with the Origin of Multiple Sclerosis.
35682458|a|Multiple sclerosis (MS) is a demyelinating disease of the central nervous system in which there is a multifocal damage to the nerve tissue. Additionally, the literature emphasizes the excessive accumulation of iron in the central nervous system of patients, which is negatively correlated with their psychophysical fitness. Iron metabolism genes polymorphisms may modulate iron deposition in the body and thus affect the clinical course of MS. We aimed to assess the frequency of HAMP, TFR2, and TF polymorphisms in MS patients and their impact on the clinical course of the disease. The studied polymorphisms were identified by the Real-Time PCR using TaqMan technology. Neurological assessment by means of EDSS scale was conducted. This cross-sectional study included 176 patients, with the mean age of onset of symptoms at 30.6 years. The frequency of alleles of the studied polymorphisms was as follows: (a) HAMP rs10421768: A 75.9% (n = 267), G 24.1% (n = 65), (b) TF rs1049296: C 89.2% (n = 314), T 10.8% (n = 38), (c) TF rs3811647: A 39.8% (n = 140), G 60.2% (n = 212), (d) TFR2 rs7385804: A 59.1% (n = 59.1%), C 40.9% (n = 144). In the codominant inheritance model of TF rs1049269, it was shown that people with the CT genotype scored statistically significantly lower points in the EDSS scale at the time of diagnosis than those with the CC genotype (CC Me = 1.5, CT Me = 1.0 p = 0.0236). In the recessive model of TF inheritance rs3811647, it was noticed that the primary relapses were significantly more frequent in patients with at least one G allele compared with those with the AA genotype (AG + GG = 81.2%, AA = 18.8%, p = 0.0354). In the overdominant model rs7385804 TFR2, it was shown that among patients with the AA genotype, multiple sclerosis occurs significantly more often in relatives in a straight line compared with people with the AC and CC genotypes (AA = 100.0%, AC + CC = 0.0%, p = 0.0437). We concluded that the studied polymorphisms might affect the clinical course of MS.
35682458	0	8	Hepcidin	Gene	57817
35682458	10	20	rs10421768	SNP	tmVar:rs10421768;VariantGroup:3;CorrespondingGene:57817;RS#:10421768;CorrespondingSpecies:9606
35682458	23	34	Transferrin	Gene	7018
35682458	36	45	rs3811647	SNP	tmVar:rs3811647;VariantGroup:2;CorrespondingGene:7018;RS#:3811647;CorrespondingSpecies:9606
35682458	47	56	rs1049296	SNP	tmVar:rs1049296;VariantGroup:1;CorrespondingGene:7018;RS#:1049296;CorrespondingSpecies:9606
35682458	62	84	Transferrin Receptor 2	Gene	7036
35682458	86	95	rs7385804	SNP	tmVar:rs7385804;VariantGroup:4;CorrespondingGene:7036;RS#:7385804;CorrespondingSpecies:9606
35682458	154	172	Multiple Sclerosis	Disease	MESH:D009103
35682458	174	192	Multiple sclerosis	Disease	MESH:D009103
35682458	194	196	MS	Disease	MESH:D009103
35682458	203	254	demyelinating disease of the central nervous system	Disease	MESH:D020278
35682458	293	295	to	Disease	
35682458	300	305	nerve	Disease	MESH:C537568
35682458	384	388	iron	Chemical	MESH:D007501
35682458	422	430	patients	Species	9606
35682458	498	502	Iron	Chemical	MESH:D007501
35682458	547	551	iron	Chemical	MESH:D007501
35682458	614	616	MS	Disease	MESH:D009103
35682458	627	629	to	Disease	
35682458	654	658	HAMP	Gene	57817
35682458	660	664	TFR2	Gene	7036
35682458	670	672	TF	Gene	2152
35682458	690	692	MS	Disease	MESH:D009103
35682458	693	701	patients	Species	9606
35682458	948	956	patients	Species	9606
35682458	1086	1090	HAMP	Gene	57817
35682458	1091	1101	rs10421768	SNP	tmVar:rs10421768;VariantGroup:3;CorrespondingGene:57817;RS#:10421768;CorrespondingSpecies:9606
35682458	1144	1146	TF	Gene	2152
35682458	1147	1156	rs1049296	SNP	tmVar:rs1049296;VariantGroup:1;CorrespondingGene:7018;RS#:1049296;CorrespondingSpecies:9606
35682458	1199	1201	TF	Gene	2152
35682458	1202	1211	rs3811647	SNP	tmVar:rs3811647;VariantGroup:2;CorrespondingGene:7018;RS#:3811647;CorrespondingSpecies:9606
35682458	1255	1259	TFR2	Gene	7036
35682458	1260	1269	rs7385804	SNP	tmVar:rs7385804;VariantGroup:4;CorrespondingGene:7036;RS#:7385804;CorrespondingSpecies:9606
35682458	1350	1352	TF	Gene	2152
35682458	1353	1362	rs1049269	SNP	tmVar:rs1049269;VariantGroup:0;CorrespondingGene:9806;RS#:1049269;CorrespondingSpecies:9606
35682458	1598	1600	TF	Gene	2152
35682458	1613	1622	rs3811647	SNP	tmVar:rs3811647;VariantGroup:2;CorrespondingGene:7018;RS#:3811647;CorrespondingSpecies:9606
35682458	1701	1709	patients	Species	9606
35682458	1847	1856	rs7385804	SNP	tmVar:rs7385804;VariantGroup:4;CorrespondingGene:7036;RS#:7385804;CorrespondingSpecies:9606
35682458	1857	1861	TFR2	Gene	7036
35682458	1887	1895	patients	Species	9606
35682458	1918	1936	multiple sclerosis	Disease	MESH:D009103
35682458	2174	2176	MS	Disease	MESH:D009103
35682458	Association	MESH:D007501	RS#:3811647;CorrespondingGene:7018
35682458	Association	MESH:D007501	57817
35682458	Association	MESH:D009103	RS#:7385804;CorrespondingGene:7036
35682458	Association	MESH:D009103	RS#:3811647;CorrespondingGene:7018
35682458	Association	MESH:D009103	RS#:10421768;CorrespondingGene:57817
35682458	Association	MESH:D007501	7036
35682458	Association	MESH:D007501	RS#:1049296;CorrespondingGene:7018
35682458	Association	MESH:D007501	2152
35682458	Association	MESH:D009103	57817
35682458	Association	MESH:D009103	2152
35682458	Association	MESH:D009103	7036
35682458	Association	MESH:D009103	RS#:1049296;CorrespondingGene:7018
35682458	Association	MESH:D009103	7018
35682458	Association	MESH:D007501	MESH:D009103
35682458	Association	MESH:D009103	7036
35682458	Association	MESH:D009103	7018
35682458	Association	MESH:D009103	57817

